Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 5,033 shares at $606.64 ($3.1M) on 2020-06-10, disclosed to the SEC on 2020-06-12.
Open-market sale of $3.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $606.64 | 149 | $90K | 2.9% |
| 2 | $606.64 | 149 | $90K | 2.9% |
| 3 | $607.64 | 251 | $153K | 4.9% |
| 4 | $607.64 | 251 | $153K | 4.9% |
| 5 | $608.62 | 330 | $201K | 6.5% |
| 6 | $608.62 | 330 |
| $201K |
| 6.5% |
| 7 | $609.48 | 161 | $98K | 3.2% |
| 8 | $609.48 | 161 | $98K | 3.2% |
| 9 | $610.41 | 202 | $123K | 4.0% |
| 10 | $610.41 | 202 | $123K | 4.0% |
| 11 | $611.46 | 164 | $100K | 3.2% |
| 12 | $611.46 | 164 | $100K | 3.2% |
| 13 | $612.52 | 265 | $162K | 5.2% |
| 14 | $612.52 | 265 | $162K | 5.2% |
| 15 | $613.03 | 5 | $3K | 0.1% |
| 16 | $615.28 | 80 | $49K | 1.6% |
| 17 | $616.19 | 99 | $61K | 2.0% |
| 18 | $616.19 | 99 | $61K | 2.0% |
| 19 | $625.00 | 1,706 | $1.1M | 34.4% |
| Total | $615.16 avg | 5,033 | $3.1M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $1.0M | — | Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |